Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Canada issues much-awaited draft STED guide

This article was originally published in Clinica

Executive Summary

Health Canada has set an implementation deadline of July 2011 to adopt the global submission document, STED, as the only format for processing licensing applications for medium- and high-risk devices (Class III and IV). To that end, it has issued for public consultation a much-awaited guidance document that outlines both Canada-specific requirements and STED-based filing requirements for device licensing applications.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts